161 related articles for article (PubMed ID: 11460001)
1. Methyl protogracillin (NSC-698792): the spectrum of cytotoxicity against 60 human cancer cell lines in the National Cancer Institute's anticancer drug screen panel.
Hu K; Yao X
Anticancer Drugs; 2001 Jul; 12(6):541-7. PubMed ID: 11460001
[TBL] [Abstract][Full Text] [Related]
2. The cytotoxicity of methyl protoneogracillin (NSC-698793) and gracillin (NSC-698787), two steroidal saponins from the rhizomes of Dioscorea collettii var. hypoglauca, against human cancer cells in vitro.
Hu K; Yao X
Phytother Res; 2003 Jun; 17(6):620-6. PubMed ID: 12820229
[TBL] [Abstract][Full Text] [Related]
3. The cytotoxicity of methyl protoneodioscin (NSC-698791) against human cancer cell lines in vitro.
Hu K; Yao XS
Anticancer Res; 2002; 22(2A):1001-5. PubMed ID: 12014616
[TBL] [Abstract][Full Text] [Related]
4. Protodioscin (NSC-698 796): its spectrum of cytotoxicity against sixty human cancer cell lines in an anticancer drug screen panel.
Hu K; Yao X
Planta Med; 2002 Apr; 68(4):297-301. PubMed ID: 11988850
[TBL] [Abstract][Full Text] [Related]
5. The cytotoxicity of methyl protodioscin against human cancer cell lines in vitro.
Hu K; Yao X
Cancer Invest; 2003 Jun; 21(3):389-93. PubMed ID: 12901285
[TBL] [Abstract][Full Text] [Related]
6. The cytotoxicity of protoneodioscin (NSC-698789), a furostanol saponin from the rhizomes of Dioscorea collettii var. hypoglauca, against human cancer cells in vitro.
Hu K; Yao X
Phytomedicine; 2002 Sep; 9(6):560-5. PubMed ID: 12403167
[TBL] [Abstract][Full Text] [Related]
7. Induction of growth inhibition and G1 arrest in human cancer cell lines by relatively low-toxic diamantane derivatives.
Wang JJ; Huang KT; Chern YT
Anticancer Drugs; 2004 Mar; 15(3):277-86. PubMed ID: 15014362
[TBL] [Abstract][Full Text] [Related]
8. The primary in vitro anticancer activity of "half-mustard type" phenothiazines in NCI's revised anticancer screening paradigm.
Wuonola MA; Palfreyman MG; Motohashi N; Kawase M; Gabay S; Gupta RR; Molnár J
Anticancer Res; 1998; 18(1A):337-48. PubMed ID: 9568100
[TBL] [Abstract][Full Text] [Related]
9. Antineoplastic agents. II. Four furostanol glycosides from rhizomes of Dioscorea collettii var. hypoglauca.
Hu K; Dong A; Yao X; Kobayashi H; Iwasaki S
Planta Med; 1997 Apr; 63(2):161-5. PubMed ID: 17252340
[TBL] [Abstract][Full Text] [Related]
10. Isolation and identification of novel selective antitumor constituents, sidrin and sidroside, from
Mostafa MAH; Khojah HMJ; Ohta T
Saudi Pharm J; 2023 Jun; 31(6):1019-1028. PubMed ID: 37234346
[TBL] [Abstract][Full Text] [Related]
11. Morphological and immunocytochemical characteristics of human tumor cell lines for use in a disease-oriented anticancer drug screen.
Stinson SF; Alley MC; Kopp WC; Fiebig HH; Mullendore LA; Pittman AF; Kenney S; Keller J; Boyd MR
Anticancer Res; 1992; 12(4):1035-53. PubMed ID: 1503399
[TBL] [Abstract][Full Text] [Related]
12. Synthesis, anticancer activity and effects on cell cycle profile and apoptosis of novel thieno[2,3-d]pyrimidine and thieno[3,2-e] triazolo[4,3-c]pyrimidine derivatives.
Kandeel MM; Refaat HM; Kassab AE; Shahin IG; Abdelghany TM
Eur J Med Chem; 2015 Jan; 90():620-32. PubMed ID: 25499930
[TBL] [Abstract][Full Text] [Related]
13. Screening for and identification of novel agents directed at renal cell carcinoma.
Mertins SD; Myers TG; Hollingshead M; Dykes D; Bodde E; Tsai P; Jefferis CA; Gupta R; Linehan WM; Alley M; Bates SE
Clin Cancer Res; 2001 Mar; 7(3):620-33. PubMed ID: 11297258
[TBL] [Abstract][Full Text] [Related]
14. Assessment of in vitro and in vivo activities in the National Cancer Institute's anticancer screen with respect to chemical structure, target specificity, and mechanism of action.
Huang R; Wallqvist A; Covell DG
J Med Chem; 2006 Mar; 49(6):1964-79. PubMed ID: 16539384
[TBL] [Abstract][Full Text] [Related]
15. Microbial metabolism of methyl protodioscin by Aspergillus niger culture--a new androstenedione producing way from steroid.
He X; Liu B; Wang G; Wang X; Su L; Qu G; Yao X
J Steroid Biochem Mol Biol; 2006 Jul; 100(1-3):87-94. PubMed ID: 16713252
[TBL] [Abstract][Full Text] [Related]
16. Anticancer activity of newly synthesized azaphenothiazines from NCI's anticancer screening bank.
Pluta K; Jeleń M; Morak-Młodawska B; Zimecki M; Artym J; Kocieba M
Pharmacol Rep; 2010; 62(2):319-32. PubMed ID: 20508288
[TBL] [Abstract][Full Text] [Related]
17. Design, Synthesis, and Evaluation of (2-(Pyridinyl)methylene)-1-tetralone Chalcones for Anticancer and Antimicrobial Activity.
Gibson MZ; Nguyen MA; Zingales SK
Med Chem; 2018; 14(4):333-343. PubMed ID: 29065840
[TBL] [Abstract][Full Text] [Related]
18. One-pot multicomponent synthesis of indole incorporated thiazolylcoumarins and their antibacterial, anticancer and DNA cleavage studies.
Gali R; Banothu J; Gondru R; Bavantula R; Velivela Y; Crooks PA
Bioorg Med Chem Lett; 2015 Jan; 25(1):106-12. PubMed ID: 25435148
[TBL] [Abstract][Full Text] [Related]
19. Web-based tools for mining the NCI databases for anticancer drug discovery.
Fang X; Shao L; Zhang H; Wang S
J Chem Inf Comput Sci; 2004; 44(1):249-57. PubMed ID: 14741034
[TBL] [Abstract][Full Text] [Related]
20. Data mining of NCI's anticancer screening database reveals mitochondrial complex I inhibitors cytotoxic to leukemia cell lines.
Glover CJ; Rabow AA; Isgor YG; Shoemaker RH; Covell DG
Biochem Pharmacol; 2007 Feb; 73(3):331-40. PubMed ID: 17109823
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
